End Tuberculosis Now Act of 2026

Today's wording of each part of the law, with what would be struck out and added. Each change also gives the bill's own instruction, word for word.

1. 22 U.S.C. 2151b-3a new sectionrewrittenby H.R. 10223 Sec. 2(a)

   104B. Assistance to combat tuberculosis.—(a) Findings.— Congress finds the following:(1) The international spread of tuberculosis (referred to in this section as "TB") and the deadly impact of TB’s continued existence constitute a continuing challenge.(2) Additional tools and resources are required to effectively diagnose, prevent, and treat TB.(3) Effectively resourced TB programs can serve as a critical platform for preventing and responding to future infectious airborne and respiratory disease pandemics.(4) The America First Global Health Strategy sets out ambitious goals to address TB that are aligned with global goals to reduce incidences and mortality rates of TB.(b) Policy.—(1) Major objectives regarding tuberculosis.— It is a major objective of the foreign assistance program of the United States to help end the TB public health emergency through accelerated actions—(A) to support the diagnosis and treatment of all adults and children with all forms of TB; and(B) to prevent new TB infections from occurring.(2) Other policies regarding tuberculosis.— It is the policy of the United States, in countries in which the United States has established a foreign assistance program under this Act, particularly in countries with the highest rates of TB and other countries with high rates of infection and transmission of TB—(A) to reduce mortality, incidence, and health costs caused by TB, including by providing support for—(i) developing and using innovative new technologies and therapies (including molecular diagnostics) to increase active case finding and rapidly diagnose and treat children and adults with all forms of TB (including latent TB), alleviate suffering, and ensure TB treatment and preventative therapy completion;(ii) expanding diagnosis and treatment for individuals with all forms of TB (including children) and expanding prophylaxis treatment to at-risk individuals (including children), household contacts, individuals with latent TB, and individuals living with HIV;(iii) ensuring high-quality TB care by closing gaps in care cascades, implementing continuous quality improvement at all levels of care, and providing related patient support;(iv) sustainable procurement of TB commodities to avoid interruptions in supply; and(v) avoiding the procurement of TB commodities of unknown quality and the payment of excessive TB commodity costs; and(B) to ensure, to the greatest extent practicable, that United States funding supports activities that simultaneously emphasize—(i) the development of comprehensive person-centered programs, including diagnosis, treatment, and prevention strategies to ensure that—(I) all individuals sick with TB receive quality diagnosis and treatment through active case finding; and(II) individuals at high risk for TB infection are identified and treated with prophylaxis treatment in a timely manner;(ii) robust TB infection control practices are implemented in all congregate settings, including hospitals and prisons;(iii) the deployment of diagnostic and treatment capacity—(I) in areas with the highest TB burdens; and(II) for highly at-risk and impoverished populations, including for patient support;(iv) program monitoring and evaluation based on critical TB indicators, including indicators relating to infection control, the numbers of patients accessing TB treatment and patient support, and prophylaxis treatment for those at risk, including all close contacts, and treatment outcomes for all forms of TB;(v) training and engagement of health care workers on the use of new diagnostic tools and therapies as they become available, and increased support for training frontline health care workers to support expanded TB active case finding, contact tracing, and patient support;(vi) coordination with domestic agencies and organizations to support an aggressive research agenda to develop vaccines as well as new tools to diagnose, treat, and prevent TB globally;(vii) linkages with the private sector on—(I) research and development of a vaccine, and on new tools for diagnosis and treatment of TB;(II) improving current tools for diagnosis and treatment of TB, including telehealth solutions for prevention and treatment;(III) training healthcare professionals on the use of the newest and most effective diagnostic and therapeutic tools; and(IV) transparency and accountability;(viii) the reduction of barriers to treatment and diagnosis costs, including through—(I) training health workers to ensure integration into country’s wider healthcare system;(II) requiring that all relevant grants and funding agreements include access and affordability provisions;(III) supporting campaigns for TB patients regarding local TB care for prevention, diagnosis, and treatment;(IV) monitoring cost barriers to accessing TB care for prevention, diagnosis, and treatment; and(V) increasing support for patient-led and community-led TB outreach efforts;(ix) support for local and country-level, sustainable accountability mechanisms to measure local progress and ensure commitments made by governments and relevant stakeholders are met; and(x) support for the inclusion of TB diagnosis, treatment, and prevention activities into primary health care, as appropriate.(c) Authorization.—(1) In general.— The President is authorized to furnish assistance, on such terms and conditions as the President may determine necessary to carry out this section, for the prevention, treatment, control, and elimination of TB.(2) Priority for assistance.— In furnishing assistance under paragraph (1), the President shall prioritize—(A) building and strengthening TB programs—(i) to increase the diagnosis and treatment of individuals who are sick with TB; and(ii) to ensure that such individuals have access to quality diagnosis and treatment;(B) direct, high-quality care for all forms of TB, including diagnosis, coordination of active case finding, treatment of all forms of TB disease and

   The bill says: Section 104B of the Foreign Assistance Act of 1961 (22 U.S.C. 2151b–3) is amended to read as follows:

   Bill text

From the bill's official text on GovInfo and the U.S. Code, latest edition, which may not yet show changes made since.